aTyr Pharma SG&A Expense (Quarterly) Trends

aTyr Pharma Inc (LIFE)

1.62 -0.02 (-1.22%) USD | NASDAQ | Apr 23, 16:00

1.62 0.00 (0.00%) After-Hours: 17:22

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	3.204M
September 30, 2023	2.649M
June 30, 2023	3.718M
March 31, 2023	3.408M
December 31, 2022	3.426M
September 30, 2022	3.625M
June 30, 2022	3.449M
March 31, 2022	3.482M
December 31, 2021	2.685M
September 30, 2021	2.59M
June 30, 2021	2.79M
March 31, 2021	2.686M
December 31, 2020	2.295M
September 30, 2020	2.044M
June 30, 2020	2.146M
March 31, 2020	2.59M
December 31, 2019	2.516M
September 30, 2019	1.883M
June 30, 2019	2.421M
March 31, 2019	2.532M

Date	Value
December 31, 2018	2.414M
September 30, 2018	2.475M
June 30, 2018	3.476M
March 31, 2018	4.07M
December 31, 2017	5.89M
September 30, 2017	3.694M
June 30, 2017	3.487M
March 31, 2017	4.007M
December 31, 2016	3.383M
September 30, 2016	3.47M
June 30, 2016	4.126M
March 31, 2016	4.115M
December 31, 2015	3.813M
September 30, 2015	3.574M
June 30, 2015	3.396M
March 31, 2015	2.329M
December 31, 2014	1.689M
September 30, 2014	1.821M
June 30, 2014	1.725M
March 31, 2014	1.542M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.883M

Minimum

Sep 2019

3.718M

Maximum

Jun 2023

2.821M

Average

2.685M

Median

Dec 2021

SG&A Expense (Quarterly) Benchmarks